Abstract


Francisco J Guarda*1, Roberto Olmos1, Ignacio San Francisco1, Alvaro Zuñiga1, Alvaro Huete1, Gonzalo Mendez1, Anand Vaidya2 and Rene Baudrand1
Pontificia Universidad Catolica de Chile, Santiago, Chile, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA

view more

Francisco J Guarda*1, Roberto Olmos1, Ignacio San Francisco1, Alvaro Zuñiga1, Alvaro Huete1, Gonzalo Mendez1, Anand Vaidya2 and Rene Baudrand1
Pontificia Universidad Catolica de Chile, Santiago, Chile, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA

INTRODUCTION: The detection of Adrenal Incidentalomas (AIs) is increasing. Current guidelines suggest that all AIs be screened for excess cortisol and cathecolamines to optimize early detection of subclinical and deleterious hormone excess, and to screen for primary aldosteronism (PA) only when there is concomitant hypertension and/or hypokalemia.

AIMS: To evaluate whether systematic and indiscriminate approach to screening for hormonal excess in AI could improve detection of adrenal hormone hyperfunction.

METHODS: We recruited 100 consecutive patients with AI. Measurements of morning ACTH, plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were performed on all participants on day 1, followed by an overnight 1mg dexamethasone suppression test (DST) on day 2. Urine metanephrines were measured only in non-adenoma cases defined by an expert radiologist.
Hypercortisolism was defined by baseline ACTH<15 pg/mL and a DST cortisol >1.8 ug/dL. PA was defined as a positive oral sodium loading or saline suppression test in participants with a positive screen for PA (aldosterone-to-renin ratio (ARR)>20, with PAC>6 ng/dL and PRA<1 ng/mL/h).

RESULTS: The mean AI size was 25mm, with 15% of cases bilateral AI. The frequency of benign appearing adenomas was 76%, carcinoma was 3%, and pheochromocytoma was 6%. Functional tumors were detected in 45/100 of the cases, and of these 25/45 were confirmed to have hypercortisolism, 12/45 were confirmed to have PA (30% normotensives), 6/45 had a pheochromocytoma and 2/45 had a secretory adrenocortical carcinoma.

CONCLUSIONS: The systematic biochemical screening of adrenal incidentalomas resulted in a high detection of subclinical adrenal hormone excess. Given the high risk of incident cardiometabolic risk associated with hypercortisolism and hyperaldosteronism, our findings suggest that an unbiased screening approach to AI may increase the detection of functional tumors.
Francisco J Guarda*1, Roberto Olmos1, Ignacio San Francisco1, Alvaro Zuñiga1, Alvaro Huete1, Gonzalo Mendez1, Anand Vaidya2 and Rene Baudrand1
1Pontificia Universidad Catolica de Chile, Santiago, Chile, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Nothing to Disclose: FJG, RO, IS, AZ, AH, GM, AV, RB

Please take note of the Endocrine Society's News Embargo Policy at: https://www.endocrine.org/news-room/endo-annual-meeting

show less
Files:

Support our sponsors


Share this PosterTalk

About PosterTalks

PosterTalks allows meeting attendees the ability to view these presentations, download or bookmark their favorite presentations, download PDF versions of the posters, ask questions, leave comments, and share presentations with their colleagues – all from the convenience of a smart phone.

Contact Us

Have a question? Click here to contact us. Need technical support? Click here to email support.

© 2018 PosterTalks and Connect BioMed. All other content and data, including data entered into this website are copyrighted by their respective owners.